Related Experiment Video
Updated: Feb 7, 2026
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Network Propagation Predicts Drug Synergy in Cancers
Hongyang Li1, Tingyang Li1, Daniel Quang1
1Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.
Abstract:
Combination therapies are commonly used to treat patients with complex diseases that respond poorly to single-agent therapies. In vitro high-throughput drug screening is a standard method for preclinical prioritization of synergistic drug combinations, but it can be impractical for large drug sets. Computational methods are thus being actively explored; however, most published methods were built on a limited size of cancer cell lines or drugs, and it remains a challenge to predict synergism at a large scale where the diversity within the data escalates the difficulty of prediction. Here, we present a state-of-the-field synergy prediction algorithm, which ranked first in all subchallenges in the AstraZeneca-Sanger Drug Combination Prediction DREAM Challenge. The model was built and evaluated using the largest drug combination screening dataset at the time of the competition, consisting of approximately 11,500 experimentally tested synergy scores of 118 drugs in 85 cancer cell lines. We developed a novel feature extraction strategy by integrating the cross-cell and cross-drug information with a novel network propagation method and then assembled the information in monotherapy and simulated molecular data to predict drug synergy. This represents a significant conceptual advancement of synergy prediction, using extracted features in the form of simulated posttreatment molecular profiles when only the pretreatment molecular profile is available. Our cross-tissue synergism prediction algorithm achieves promising accuracy comparable with the correlation between experimental replicates and can be applied to other cancer cell lines and drugs to guide therapeutic choices.Significance: This study presents a novel network propagation-based method that predicts anticancer drug synergy to the accuracy of experimental replicates, which establishes a state-of-the-field method as benchmarked by the pharmacogenomics research community involving models generated by 160 teams. Cancer Res; 78(18); 5446-57. ©2018 AACR.
Insights
Predicting synergistic drug combinations for complex diseases is challenging. This study introduces a novel network propagation algorithm that accurately predicts anticancer drug synergy, achieving performance comparable to experimental replicates.
Area of Science:
- Pharmacogenomics and Computational Biology
- Drug Discovery and Development
- Cancer Therapeutics
Background:
- Combination therapies are crucial for complex diseases but preclinical screening is often impractical for large drug sets.
- Existing computational methods for predicting drug synergy are limited by small datasets and struggle with data diversity.
- Accurate prediction of drug synergy is essential for efficient preclinical prioritization and guiding therapeutic choices.
Purpose of the Study:
- To develop a state-of-the-field computational algorithm for predicting anticancer drug synergy at scale.
- To address the limitations of existing methods by integrating diverse data and employing novel feature extraction strategies.
- To establish a benchmark for drug synergy prediction accuracy, comparable to experimental reliability.
Main Methods:
- Developed a novel network propagation method for feature extraction, integrating cross-cell and cross-drug information.
- Utilized the largest available drug combination screening dataset (~11,500 synergy scores, 118 drugs, 85 cancer cell lines) for model training and evaluation.
- Simulated posttreatment molecular profiles from pretreatment data to predict drug synergy, advancing predictive capabilities.
Main Results:
- The developed algorithm ranked first in all subchallenges of the AstraZeneca-Sanger Drug Combination Prediction DREAM Challenge.
- Achieved prediction accuracy comparable to the correlation between experimental replicates, demonstrating high reliability.
- The model successfully integrated diverse data sources and demonstrated robust performance on unseen cancer cell lines and drugs.
Conclusions:
- The novel network propagation-based method represents a significant advancement in predicting anticancer drug synergy.
- The algorithm's accuracy and scalability provide a powerful tool for guiding therapeutic choices in complex diseases.
- This state-of-the-field method sets a new benchmark for computational drug synergy prediction in pharmacogenomics research.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:27Predicting Molecular Geometry
01:07Propagation of Waves
Consider a scenario where a wave propagates from a string of low linear mass density to a string of high linear mass density. In such a case, the reflected wave is out of phase with respect to the incident wave, however the...
02:18Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
01:23Propagation of Action Potentials
Neurons (nerve cells) have a resting membrane potential, with a slightly negative charge inside compared to outside. This is maintained by ion channels, such as sodium (Na+) and potassium (K+) channels, which control the flow of ions. When a stimulus, like a touch or a signal from another neuron, triggers the neuron, sodium channels open, allowing sodium ions to...
01:03Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.